ASCO 2025 — Let’s Talk About What’s Next in Oncology

Read article

Chinese Clinical Trial Data – Still Relevant to the FDA

For Chinese companies bringing oncology drugs to the…
Read Article

A Decade Later, Patient Receiving CAR T-Cell Therapy “Cured of Cancer”

February 2022 has been an important month in…
Read Article

Rescuing an Oncology Study in the U.S.

When startup biotech or pharma companies are conducting…
Read Article

CAR T-Cell Therapies – Now Targeting Solid Tumors

Most in oncology drug development are aware of…
Read Article

How to Avoid Missing Patient Enrollment Targets in Your First Oncology Study

It’s common for sponsors to miss their patient…
Read Article

Cancer Vaccines – Promising Research Gets Closer to Reality

Vaccines are at the top of everyone’s mind…
Read Article

Selecting a CRO During the COVID-19 Pandemic

In 2014, we wrote a popular post about…
Read Article

Tips for Bringing Your First Oncology Drug into the Clinic in the United States

While cancer is a global health challenge, the…
Read Article

FDA Guidance on Conduct of Clinical Trials During COVID-19

These are challenging times, as the world grapples…
Read Article